Company Overview and News

1
Shares fall as global tensions keep investors on the sidelines

2018-04-16 nzherald.co.nz
New Zealand shares fell in relatively subdued trading, led by Ebos Group, Ryman Healthcare, Air New Zealand and Fletcher Building. Comvita fell after a profit warning while A2 Milk gained on news of a deal in South Korea.

 
MARKET CLOSE: NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nbr.co.nz
(BusinessDesk) - New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent weakness and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.

 
NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nzherald.co.nz
New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent selling and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.

 
MARKET CLOSE: NZ shares join global rally as trade fears ease; Chorus, Mainfreight rise

2018-03-06 nbr.co.nz
New Zealand shares rose as fears eased over US President Donald Trump's new tariffs on metals, renewing demand for equities across the world. Chorus and Mainfreight gained, while Metro Performance Glass fell, matching its record low.

 
NZ shares join global rally as trade fears ease

2018-03-06 nzherald.co.nz
New Zealand shares rose as fears eased over US President Donald Trump's new tariffs on metals, renewing demand for equities across the world. Chorus and Mainfreight gained, while Metro Performance Glass fell, matching its record low.

 
Sharemarket falls as Sky TV hits record low

2018-03-05 nzherald.co.nz
New Zealand shares fell as Sky Network Television sank to a record low having halved its interim dividend and cut prices last month in the face of increased competition. Air New Zealand and Fisher & Paykel Healthcare gained.

 
MARKET CLOSE: NZ shares fall with Sky

2018-03-05 nbr.co.nz
(BusinessDesk) - New Zealand shares fell as Sky Network Television sank to a record low having halved its interim dividend and cut prices last month in the face of increased competition. Air New Zealand and Fisher & Paykel Healthcare gained.

 
EBOS Group, Ltd. ADR 2018 Q2 - Results - Earnings Call Slides

2018-02-21 seekingalpha
The following slide deck was published by EBOS Group, Ltd. ADR in conjunction with their 2018 Q2 earnings call.

 
Sharemarket jumps on A2 Milk's 27% surge

2018-02-21 nzherald.co.nz
New Zealand shares rose as A2 Milk Co surged on its tie-up with Fonterra Cooperative Group, while Synlait Milk, Fletcher Building and Spark New Zealand dropped.

 
Sharemarket falls on eve of big day for company results

2018-02-20 nzherald.co.nz
New Zealand shares fell in light trading ahead of a busy day of earnings tomorrow, with Heartland Bank and Fletcher Building dropping while Sky Network Television and Air New Zealand rose.

 
Shares up; Tourism Holdings hits record with Auckland Airport, Fletcher Building gaining

2018-02-16 nzherald.co.nz
New Zealand shares rallied as Tourism Holdings hit a record and Auckland Airport gained on its first-half earnings.

 
Big sell off drives sharemarket down 2.1 per cent

2018-02-05 nzherald.co.nz
New Zealand shares fell following a selloff on Wall Street on Friday, with index futures pointing to further US weakness. Pushpay Holdings, Kathmandu Holdings, Synlait Milk, Summerset Group, Fisher & Paykel Healthcare, a2 Milk and Ebos Group all dropped more than 3 per cent.

 
NZ shares edge up as NZX leads late recovery, Air New Zealand falls

2017-12-13 nzherald.co.nz
New Zealand shares edged up to a new record, led by stock market operator NZX and as investors changed their tune on a2 Milk Co late in the day. Air New Zealand fell on disappointing monthly metrics.

2
Investors take profits on top milk stocks

2017-11-07 nzherald.co.nz
New Zealand shares fell as A2 Milk and Synlait Milk, the best-performing companies on the benchmark index this year, extended their decline amid speculation investors who enjoyed the run-up are now booking profits.

 
Market's 15-day winning streak ends

2017-10-25 nzherald.co.nz
New Zealand shares dipped, ending a 15-day streak of gains as Fletcher Building's stock fell. Comvita, A2 Milk and retirement village stocks gained.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...